Respiratory Antivirals and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Respiratory Antivirals Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Respiratory Antivirals Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Respiratory Antivirals Overall Market Size
2.1 Global Respiratory Antivirals Market Size: 2022 VS 2029
2.2 Global Respiratory Antivirals Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Respiratory Antivirals Players in Global Market
3.2 Top Global Respiratory Antivirals Companies Ranked by Revenue
3.3 Global Respiratory Antivirals Revenue by Companies
3.4 Top 3 and Top 5 Respiratory Antivirals Companies in Global Market, by Revenue in 2022
3.5 Global Companies Respiratory Antivirals Product Type
3.6 Tier 1, Tier 2 and Tier 3 Respiratory Antivirals Players in Global Market
3.6.1 List of Global Tier 1 Respiratory Antivirals Companies
3.6.2 List of Global Tier 2 and Tier 3 Respiratory Antivirals Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Respiratory Antivirals Market Size Markets, 2022 & 2029
4.1.2 Nucleoside Analogs
4.1.3 Neuraminidase Inhibitors
4.1.4 Ion Channel Blockers
4.1.5 Fusion Protein Inhibitors
4.2 By Type - Global Respiratory Antivirals Revenue & Forecasts
4.2.1 By Type - Global Respiratory Antivirals Revenue, 2018-2023
4.2.2 By Type - Global Respiratory Antivirals Revenue, 2024-2029
4.2.3 By Type - Global Respiratory Antivirals Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Respiratory Antivirals Market Size, 2022 & 2029
5.1.2 Upper Respiratory Tract Infections (URTIs)
5.1.3 Influenza
5.1.4 Bronchiolitis
5.1.5 Pneumonia
5.1.6 Measles
5.1.7 Others
5.2 By Application - Global Respiratory Antivirals Revenue & Forecasts
5.2.1 By Application - Global Respiratory Antivirals Revenue, 2018-2023
5.2.2 By Application - Global Respiratory Antivirals Revenue, 2024-2029
5.2.3 By Application - Global Respiratory Antivirals Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Respiratory Antivirals Market Size, 2022 & 2029
6.2 By Region - Global Respiratory Antivirals Revenue & Forecasts
6.2.1 By Region - Global Respiratory Antivirals Revenue, 2018-2023
6.2.2 By Region - Global Respiratory Antivirals Revenue, 2024-2029
6.2.3 By Region - Global Respiratory Antivirals Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Respiratory Antivirals Revenue, 2018-2029
6.3.2 US Respiratory Antivirals Market Size, 2018-2029
6.3.3 Canada Respiratory Antivirals Market Size, 2018-2029
6.3.4 Mexico Respiratory Antivirals Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Respiratory Antivirals Revenue, 2018-2029
6.4.2 Germany Respiratory Antivirals Market Size, 2018-2029
6.4.3 France Respiratory Antivirals Market Size, 2018-2029
6.4.4 U.K. Respiratory Antivirals Market Size, 2018-2029
6.4.5 Italy Respiratory Antivirals Market Size, 2018-2029
6.4.6 Russia Respiratory Antivirals Market Size, 2018-2029
6.4.7 Nordic Countries Respiratory Antivirals Market Size, 2018-2029
6.4.8 Benelux Respiratory Antivirals Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Respiratory Antivirals Revenue, 2018-2029
6.5.2 China Respiratory Antivirals Market Size, 2018-2029
6.5.3 Japan Respiratory Antivirals Market Size, 2018-2029
6.5.4 South Korea Respiratory Antivirals Market Size, 2018-2029
6.5.5 Southeast Asia Respiratory Antivirals Market Size, 2018-2029
6.5.6 India Respiratory Antivirals Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Respiratory Antivirals Revenue, 2018-2029
6.6.2 Brazil Respiratory Antivirals Market Size, 2018-2029
6.6.3 Argentina Respiratory Antivirals Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Respiratory Antivirals Revenue, 2018-2029
6.7.2 Turkey Respiratory Antivirals Market Size, 2018-2029
6.7.3 Israel Respiratory Antivirals Market Size, 2018-2029
6.7.4 Saudi Arabia Respiratory Antivirals Market Size, 2018-2029
6.7.5 UAE Respiratory Antivirals Market Size, 2018-2029
7 Respiratory Antivirals Companies Profiles
7.1 GSK
7.1.1 GSK Company Summary
7.1.2 GSK Business Overview
7.1.3 GSK Respiratory Antivirals Major Product Offerings
7.1.4 GSK Respiratory Antivirals Revenue in Global Market (2018-2023)
7.1.5 GSK Key News & Latest Developments
7.2 Boehringer Ingelheim
7.2.1 Boehringer Ingelheim Company Summary
7.2.2 Boehringer Ingelheim Business Overview
7.2.3 Boehringer Ingelheim Respiratory Antivirals Major Product Offerings
7.2.4 Boehringer Ingelheim Respiratory Antivirals Revenue in Global Market (2018-2023)
7.2.5 Boehringer Ingelheim Key News & Latest Developments
7.3 AstraZeneca
7.3.1 AstraZeneca Company Summary
7.3.2 AstraZeneca Business Overview
7.3.3 AstraZeneca Respiratory Antivirals Major Product Offerings
7.3.4 AstraZeneca Respiratory Antivirals Revenue in Global Market (2018-2023)
7.3.5 AstraZeneca Key News & Latest Developments
7.4 Merck
7.4.1 Merck Company Summary
7.4.2 Merck Business Overview
7.4.3 Merck Respiratory Antivirals Major Product Offerings
7.4.4 Merck Respiratory Antivirals Revenue in Global Market (2018-2023)
7.4.5 Merck Key News & Latest Developments
7.5 Novartis
7.5.1 Novartis Company Summary
7.5.2 Novartis Business Overview
7.5.3 Novartis Respiratory Antivirals Major Product Offerings
7.5.4 Novartis Respiratory Antivirals Revenue in Global Market (2018-2023)
7.5.5 Novartis Key News & Latest Developments
7.6 Beximco Pharmaceuticals
7.6.1 Beximco Pharmaceuticals Company Summary
7.6.2 Beximco Pharmaceuticals Business Overview
7.6.3 Beximco Pharmaceuticals Respiratory Antivirals Major Product Offerings
7.6.4 Beximco Pharmaceuticals Respiratory Antivirals Revenue in Global Market (2018-2023)
7.6.5 Beximco Pharmaceuticals Key News & Latest Developments
7.7 Pfizer
7.7.1 Pfizer Company Summary
7.7.2 Pfizer Business Overview
7.7.3 Pfizer Respiratory Antivirals Major Product Offerings
7.7.4 Pfizer Respiratory Antivirals Revenue in Global Market (2018-2023)
7.7.5 Pfizer Key News & Latest Developments
7.8 Roche
7.8.1 Roche Company Summary
7.8.2 Roche Business Overview
7.8.3 Roche Respiratory Antivirals Major Product Offerings
7.8.4 Roche Respiratory Antivirals Revenue in Global Market (2018-2023)
7.8.5 Roche Key News & Latest Developments
7.9 Bristol-Myers Squibb Company
7.9.1 Bristol-Myers Squibb Company Company Summary
7.9.2 Bristol-Myers Squibb Company Business Overview
7.9.3 Bristol-Myers Squibb Company Respiratory Antivirals Major Product Offerings
7.9.4 Bristol-Myers Squibb Company Respiratory Antivirals Revenue in Global Market (2018-2023)
7.9.5 Bristol-Myers Squibb Company Key News & Latest Developments
7.10 Johnson & Johnson
7.10.1 Johnson & Johnson Company Summary
7.10.2 Johnson & Johnson Business Overview
7.10.3 Johnson & Johnson Respiratory Antivirals Major Product Offerings
7.10.4 Johnson & Johnson Respiratory Antivirals Revenue in Global Market (2018-2023)
7.10.5 Johnson & Johnson Key News & Latest Developments
7.11 AbbVie Inc.
7.11.1 AbbVie Inc. Company Summary
7.11.2 AbbVie Inc. Business Overview
7.11.3 AbbVie Inc. Respiratory Antivirals Major Product Offerings
7.11.4 AbbVie Inc. Respiratory Antivirals Revenue in Global Market (2018-2023)
7.11.5 AbbVie Inc. Key News & Latest Developments
7.12 Sanofi
7.12.1 Sanofi Company Summary
7.12.2 Sanofi Business Overview
7.12.3 Sanofi Respiratory Antivirals Major Product Offerings
7.12.4 Sanofi Respiratory Antivirals Revenue in Global Market (2018-2023)
7.12.5 Sanofi Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Respiratory Antivirals Market Opportunities & Trends in Global Market
Table 2. Respiratory Antivirals Market Drivers in Global Market
Table 3. Respiratory Antivirals Market Restraints in Global Market
Table 4. Key Players of Respiratory Antivirals in Global Market
Table 5. Top Respiratory Antivirals Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Respiratory Antivirals Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Respiratory Antivirals Revenue Share by Companies, 2018-2023
Table 8. Global Companies Respiratory Antivirals Product Type
Table 9. List of Global Tier 1 Respiratory Antivirals Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Respiratory Antivirals Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Respiratory Antivirals Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Respiratory Antivirals Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Respiratory Antivirals Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Respiratory Antivirals Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Respiratory Antivirals Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Respiratory Antivirals Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Respiratory Antivirals Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Respiratory Antivirals Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Respiratory Antivirals Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Respiratory Antivirals Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Respiratory Antivirals Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Respiratory Antivirals Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Respiratory Antivirals Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Respiratory Antivirals Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Respiratory Antivirals Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Respiratory Antivirals Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Respiratory Antivirals Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Respiratory Antivirals Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Respiratory Antivirals Revenue, (US$, Mn), 2024-2029
Table 30. GSK Company Summary
Table 31. GSK Respiratory Antivirals Product Offerings
Table 32. GSK Respiratory Antivirals Revenue (US$, Mn) & (2018-2023)
Table 33. GSK Key News & Latest Developments
Table 34. Boehringer Ingelheim Company Summary
Table 35. Boehringer Ingelheim Respiratory Antivirals Product Offerings
Table 36. Boehringer Ingelheim Respiratory Antivirals Revenue (US$, Mn) & (2018-2023)
Table 37. Boehringer Ingelheim Key News & Latest Developments
Table 38. AstraZeneca Company Summary
Table 39. AstraZeneca Respiratory Antivirals Product Offerings
Table 40. AstraZeneca Respiratory Antivirals Revenue (US$, Mn) & (2018-2023)
Table 41. AstraZeneca Key News & Latest Developments
Table 42. Merck Company Summary
Table 43. Merck Respiratory Antivirals Product Offerings
Table 44. Merck Respiratory Antivirals Revenue (US$, Mn) & (2018-2023)
Table 45. Merck Key News & Latest Developments
Table 46. Novartis Company Summary
Table 47. Novartis Respiratory Antivirals Product Offerings
Table 48. Novartis Respiratory Antivirals Revenue (US$, Mn) & (2018-2023)
Table 49. Novartis Key News & Latest Developments
Table 50. Beximco Pharmaceuticals Company Summary
Table 51. Beximco Pharmaceuticals Respiratory Antivirals Product Offerings
Table 52. Beximco Pharmaceuticals Respiratory Antivirals Revenue (US$, Mn) & (2018-2023)
Table 53. Beximco Pharmaceuticals Key News & Latest Developments
Table 54. Pfizer Company Summary
Table 55. Pfizer Respiratory Antivirals Product Offerings
Table 56. Pfizer Respiratory Antivirals Revenue (US$, Mn) & (2018-2023)
Table 57. Pfizer Key News & Latest Developments
Table 58. Roche Company Summary
Table 59. Roche Respiratory Antivirals Product Offerings
Table 60. Roche Respiratory Antivirals Revenue (US$, Mn) & (2018-2023)
Table 61. Roche Key News & Latest Developments
Table 62. Bristol-Myers Squibb Company Company Summary
Table 63. Bristol-Myers Squibb Company Respiratory Antivirals Product Offerings
Table 64. Bristol-Myers Squibb Company Respiratory Antivirals Revenue (US$, Mn) & (2018-2023)
Table 65. Bristol-Myers Squibb Company Key News & Latest Developments
Table 66. Johnson & Johnson Company Summary
Table 67. Johnson & Johnson Respiratory Antivirals Product Offerings
Table 68. Johnson & Johnson Respiratory Antivirals Revenue (US$, Mn) & (2018-2023)
Table 69. Johnson & Johnson Key News & Latest Developments
Table 70. AbbVie Inc. Company Summary
Table 71. AbbVie Inc. Respiratory Antivirals Product Offerings
Table 72. AbbVie Inc. Respiratory Antivirals Revenue (US$, Mn) & (2018-2023)
Table 73. AbbVie Inc. Key News & Latest Developments
Table 74. Sanofi Company Summary
Table 75. Sanofi Respiratory Antivirals Product Offerings
Table 76. Sanofi Respiratory Antivirals Revenue (US$, Mn) & (2018-2023)
Table 77. Sanofi Key News & Latest Developments
List of Figures
Figure 1. Respiratory Antivirals Segment by Type in 2022
Figure 2. Respiratory Antivirals Segment by Application in 2022
Figure 3. Global Respiratory Antivirals Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Respiratory Antivirals Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Respiratory Antivirals Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Respiratory Antivirals Revenue in 2022
Figure 8. By Type - Global Respiratory Antivirals Revenue Market Share, 2018-2029
Figure 9. By Application - Global Respiratory Antivirals Revenue Market Share, 2018-2029
Figure 10. By Type - Global Respiratory Antivirals Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Respiratory Antivirals Revenue Market Share, 2018-2029
Figure 12. By Application - Global Respiratory Antivirals Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Respiratory Antivirals Revenue Market Share, 2018-2029
Figure 14. By Region - Global Respiratory Antivirals Revenue Market Share, 2018-2029
Figure 15. By Country - North America Respiratory Antivirals Revenue Market Share, 2018-2029
Figure 16. US Respiratory Antivirals Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Respiratory Antivirals Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Respiratory Antivirals Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Respiratory Antivirals Revenue Market Share, 2018-2029
Figure 20. Germany Respiratory Antivirals Revenue, (US$, Mn), 2018-2029
Figure 21. France Respiratory Antivirals Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Respiratory Antivirals Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Respiratory Antivirals Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Respiratory Antivirals Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Respiratory Antivirals Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Respiratory Antivirals Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Respiratory Antivirals Revenue Market Share, 2018-2029
Figure 28. China Respiratory Antivirals Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Respiratory Antivirals Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Respiratory Antivirals Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Respiratory Antivirals Revenue, (US$, Mn), 2018-2029
Figure 32. India Respiratory Antivirals Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Respiratory Antivirals Revenue Market Share, 2018-2029
Figure 34. Brazil Respiratory Antivirals Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Respiratory Antivirals Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Respiratory Antivirals Revenue Market Share, 2018-2029
Figure 37. Turkey Respiratory Antivirals Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Respiratory Antivirals Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Respiratory Antivirals Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Respiratory Antivirals Revenue, (US$, Mn), 2018-2029
Figure 41. GSK Respiratory Antivirals Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Boehringer Ingelheim Respiratory Antivirals Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. AstraZeneca Respiratory Antivirals Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Merck Respiratory Antivirals Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Novartis Respiratory Antivirals Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Beximco Pharmaceuticals Respiratory Antivirals Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Pfizer Respiratory Antivirals Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Roche Respiratory Antivirals Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Bristol-Myers Squibb Company Respiratory Antivirals Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Johnson & Johnson Respiratory Antivirals Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. AbbVie Inc. Respiratory Antivirals Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Sanofi Respiratory Antivirals Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Industry Market Size
